NASDAQ:DRVN

Driven Brands Holdings Inc. (NASDAQ:DRVN) Financial Overview and Challenges

Font: Financial Modeling Prep  • Mar 02, 2026

Market Chart
  • Earnings Per Share (EPS) of $0.29 exceeded the estimated EPS of $0.28.
  • Actual revenue of approximately $457.3 million fell slightly short of the estimated $458.6 million.
  • High debt-to-equity ratio of approximately 3.47, indicating significant reliance on debt financing.

Driven Brands Holdings Inc. (NASDAQ:DRVN) is a prominent player in the automotive services industry, offering a range of services including car repair, maintenance, and car wash. Despite its strong market presence, DRVN faces competition from other automotive service providers. On March 2, 2026, DRVN reported its earnings, revealing an earnings per share (EPS) of $0.29, which exceeded the estimated EPS of $0.28.

However, DRVN's actual revenue of approximately $457.3 million fell slightly short of the estimated $458.6 million. The company's financial health is further complicated by a high debt-to-equity ratio of approximately 3.47, suggesting a significant reliance on debt financing. This could pose risks, especially in light of the ongoing fraud investigation by the Schall Law Firm, which specializes in securities class action lawsuits. This investigation could have significant implications for DRVN and its investors.

DRVN's price-to-sales ratio of about 0.83 indicates that investors are paying $0.83 for every dollar of sales, which is relatively low. However, the enterprise value to sales ratio of around 2.00 and the enterprise value to operating cash flow ratio of approximately 16.12 suggest that the company may be overvalued relative to its cash flow generation capabilities.

Additionally, DRVN's current ratio of around 0.90 points to potential liquidity challenges in covering short-term liabilities. This could be a concern for investors, especially given the ongoing investigation and the company's financial metrics. Investors should closely monitor these developments and consider the potential risks associated with DRVN's financial position.

Market Overview
BRTX
BioRestorative Therapies, Inc.
$0.28
21.98%
SGN
Signing Day Sports, Inc.
$0.73
36.04%
LGVN
Longeveron Inc.
$1.06
100.25%
NIO
NIO Inc.
$5.47
10.77%
DXST
Decent Holding Inc.
$0.38
44.79%
VTAK
Catheter Precision, Inc.
$1.97
43.43%
HIMS
Hims & Hers Health, Inc.
$24.00
8.30%
HIMZ
Daily Target 2X Long HIMS ETF
$2.35
15.81%
RENX
RenX Enterprises Corp.
$0.13
-3.66%
SOXL
Direxion Daily Semiconductor Bull 3X ETF
$55.29
3.69%